|国家科技期刊平台
首页|期刊导航|心脑血管病防治|肝素结合蛋白、核因子κB亚基p65及神经元特异性烯醇化酶与心脏骤停患者预后的相关性

肝素结合蛋白、核因子κB亚基p65及神经元特异性烯醇化酶与心脏骤停患者预后的相关性OACSTPCD

Correlation of heparin-binding protein,nuclear factor Kappa B p65 and neuron-specific enolase with the prognosis of cardiac arrest patients

中文摘要英文摘要

目的 分析心肺复苏(CPR)患者血清肝素结合蛋白(HBP)、核因子κB(NF-κB)亚基 p65 及神经元特异性烯醇化酶(NSE)对预后的影响.方法 收集 2020 年 9 月至 2022 年9 月杭州师范大学附属医院急诊重症监护室接受治疗的心脏骤停(CA)患者,经CPR后,将满足入选条件且存活超过48 h的CPR患者纳入分析,根据患者入院治疗1个月后格拉斯哥-匹兹堡脑功能表现分级(CPC)分为预后良好组(CPC评分 1~2 级)和预后不良组(CPC评分 3~5 级),并记录两组性别、年龄、基础疾病及CA原因.同时,分别于自主循环恢复(ROSC)即刻、ROSC后6 h、12 h、24 h、48 h五个时间点采集其外周血,监测CPR患者血清HBP、NF-κB亚基p65、NSE的变化,分析HBP、NF-κB亚基p65 及NSE与急性生理与慢性健康状况(APACHE)Ⅱ评分、格拉斯哥昏迷评分(GCS)的相关性,并采用ROC曲线分析判断HBP、NF-κB亚基p65及NSE对CPR预后的影响.结果 最终共有 30 例患者CPR成功并存活超过48 h.其中预后良好组 11 例,预后不良组 19 例.预后不良组HBP、NF-κB亚基p65、NSE、APACHE Ⅱ评分较预后良好组升高,预后良好组GCS评分高于预后不良组,差异具有统计学意义(P<0.05).HBP、NF-κB亚基p65、NSE在CPR后分别在ROSC后6 h、12 h、24 h达到最高峰.血清HBP、NF-κB亚基p65、NSE均与APACHEⅡ评分呈正相关(P<0.01),与GCS评分呈负相关(P<0.01).ROC曲线分析显示HBP、NF-κB亚基p65、NSE判断CPR预后AUC分别为0.871、0.579、0.802,敏感度分别为96.3%、81.1%、93.8%,特异度分别为91.1%、78.2%、97.8%,提示HBP、NF-κB亚基p65及NSE均可预测CPR患者预后的严重程度.HBP、NF-κB亚基p65、NSE联合预测CPR患者预后不良的AUC和敏感度分别为0.953、97.7%,均高于单一指标预测(P<0.05).结论 CA患者CPR后出现不同程度的炎症反应和神经功能损伤,HBP、NF-κB亚基p65及NSE可用于早期评估复苏后患者病情严重程度及判断预后,且三者联合价值更高.

Objective To analyze the impact of serum heparin-binding protein(HBP),nuclear factor Kappa B(NF-κB)subunit p65 and neuron-specific enolase(NSE)on the prognosis of patients underwent cardiopulmonary resuscitation(CPR).Methods Patients who experienced cardiac arrest(CA)and were treated at the emergency intensive care unit of the Affiliated Hospital of Hangzhou Normal University from September 2020 to September 2022 were included.Afer CPR,patients who met the inclusion criteria and survived for more than 48 hours were included in the analysis.According to the Glasgow-Pittsburgh cerebral performance category(CPC)score at one month after admission,patients were divided into the good prognosis group(CPC score 1-2 grade)and the poor prognosis group(CPC score 3-5 grade).Gender,age,underlying diseases,and CA causes of the two groups were recorded.Peripheral blood samples were collected at five time points:immediately after return of spontaneous circulation(ROSC),and at 6,12,24,and 48 hours post-ROSC.Changes in serum HBP,NF-κB p65 and NSE were monitored.The correlation of HBP,NF-κB p65 and NSE with scores of acute physiology and chronic health evaluation(APACHE)Ⅱ and Glasgow Coma Scale(GCS)was analyzed.ROC curve analysis was performed to assess the impact of HBP,NF-κB p65,and NSE on the prognosis of CPR.Results Thirty patients successfully underwent CPR and survived for more than 48 hours,with 11 in the good prognosis group and 19 in the poor prognosis group.HBP,NF-κB p65,NSE and APACHEⅡ score in the poor prognosis group were significantly higher than those in the good prognosis group,and GCS score in the good prognosis group was significantly higher than that in the poor prognosis group,the differences were statistically significant(all P<0.05).HBP,NF-κB p65,and NSE levels,peaked at 6,12,and 24 hours post-ROSC after CPR.Serum HBP,NF-κB p65,and NSE were positively correlated with APACHEⅡ score(P<0.01)and negatively correlated with GCS score(P<0.01).ROC curve analysis showed that the AUC of HBP,NF-κB p65 and NSE for prognosis of CPR were 0.871,0.579 and 0.802,respectively,the sensitivity was 96.3%,81.1%and 93.8%,and the specificity was 91.1%,78.2%and 97.8%,respectively.These results indicated that HBP,NF-κB p65 and NSE can predict the prognosis of patients with CPR.HBP,NF-κB p65,and NSE collectively predicted poor CPR outcomes with AUC of 0.953 and sensitivity of 97.7%,surpassing individual indicators(P<0.05).Conclusion Post-CPR patients exhibit different degrees of inflammation and neural damage.HBP,NF-κB p65,and NSE can be used for early evaluation of the severity and prognosis of patients after CPR.Combined use of the 3 indicators enhances their predictive value.

苟涛;金晓宇;夏金明

310015 杭州,杭州师范大学附属医院急诊科

心肺复苏肝素结合蛋白核因子κB亚基p65神经元特异性烯醇化酶

Cardiopulmonary resuscitationHeparin-binding proteinNuclear factor Kappa B subunit p65Neuron-specific enolase

《心脑血管病防治》 2024 (007)

27-30,47 / 5

杭州市医药卫生科技项目(A20220070)

10.3969/j.issn.1009-816x.2024.07.005

评论